0001192482-20-000121.txt : 20200205
0001192482-20-000121.hdr.sgml : 20200205
20200205162138
ACCESSION NUMBER: 0001192482-20-000121
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200203
FILED AS OF DATE: 20200205
DATE AS OF CHANGE: 20200205
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bayley Matthew D
CENTRAL INDEX KEY: 0001723040
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35112
FILM NUMBER: 20579024
MAIL ADDRESS:
STREET 1: C/O AEVI GENOMIC MEDICINE, INC.
STREET 2: 435 DEVON PARK DR., SUITE 715
CITY: WAYNE
STATE: PA
ZIP: 19087
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aevi Genomic Medicine, Inc.
CENTRAL INDEX KEY: 0001138776
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 980217544
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 435 DEVON PARK DRIVE,
STREET 2: SUITE 715
CITY: WAYNE
STATE: PA
ZIP: 19087
BUSINESS PHONE: 610-254-4201
MAIL ADDRESS:
STREET 1: 435 DEVON PARK DRIVE,
STREET 2: SUITE 715
CITY: WAYNE
STATE: PA
ZIP: 19087
FORMER COMPANY:
FORMER CONFORMED NAME: MEDGENICS, INC.
DATE OF NAME CHANGE: 20090623
FORMER COMPANY:
FORMER CONFORMED NAME: MEDGENICS INC
DATE OF NAME CHANGE: 20010419
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2020-02-03
1
0001138776
Aevi Genomic Medicine, Inc.
GNMX
0001723040
Bayley Matthew D
C/O AEVI GENOMIC MEDICINE, INC.
435 DEVON PARK DRIVE, SUITE 715
WAYNE
PA
19087
1
0
0
0
Stock Option (Right to Purchase)
1.25
2020-02-03
4
D
0
40000
0
D
2027-12-04
Common Stock
40000
0
D
Stock Option (Right to Purchase)
1.55
2020-02-03
4
D
0
50000
0
D
2028-04-17
Common Stock
50000
0
D
This option, which became exercisable on December 4, 2018, was automatically cancelled and ceased to exist without any consideration or payment pursuant to the previously announced Agreement and Plan of Merger and Reorganization by and among Cerecor Inc. ("Cerecor"), Genie Merger Sub, Inc., Second Genie Merger Sub, LLC and issuer (the "Merger").
This option, which became exercisable on April 17, 2019, was automatically cancelled and ceased to exist without any consideration or payment pursuant to the Merger.
/s/ Matthew D. Bayley
2020-02-05